Labetalol: bioavailability, drug plasma levels, plasma renin and catecholamines in acute and chronic treatment of resistant hypertension.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001682:Biological Availability; D002740:Chlorothiazide / Q000008:administration & dosage; D003518:Cyclopenthiazide / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004837:Epinephrine / Q000097:blood; D004983:Ethanolamines / Q000378:metabolism*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000378:metabolism; D007275:Injections, Intravenous; D007741:Labetalol / Q000008:administration & dosage / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000097:blood; D012083:Renin / Q000097:blood
D004983:Ethanolamines; D002740:Chlorothiazide; D012083:Renin; D007741:Labetalol; D003518:Cyclopenthiazide; D009638:Norepinephrine; D004837:Epinephrine